Rockville, United States, December 31: The U.S. Food and Drug Administration Tuesday approved the cobas TaqScreen MPX Test, the first nucleic acid test that screens for the presence o
“With the MPX test, blood donor testing laboratories will be able to use nucleic acid technology to screen for additional HIVdefine strains, further assuring that donated blood and tissue are free from infection and providing better protection for patients,” said Jesse L. Goodman, M.D., M.P.H., director of the FDA’s Center for Biologics Evaluation and Research.
